GCLC公司
KEAP1型
GCLM公司
谷氨酰胺分解
炎症
甲型流感病毒
病毒
免疫学
病毒学
生物
医学
谷氨酰胺
转录因子
基因
下调和上调
氨基酸
生物化学
作者
Chengcheng Liu,Xinhao Wu,Xin Bing,Wenwen Qi,Fangyuan Zhu,Na Guo,Chengzhilin Li,Xiaochen Gao,Xue Cao,Miaoqing Zhao,Ming Xia
标识
DOI:10.1016/j.freeradbiomed.2023.05.004
摘要
Influenza A virus can induce nasal inflammation by stimulating the death of nasal mucosa epithelium, however, the mechanism is not clear. In this study, to study the causes and mechanisms of nasal mucosa epithelial cell death caused by Influenza A virus H1N1, we isolated and cultured human nasal epithelial progenitor cells (hNEPCs) and exposed them to H1N1 virus after leading differentiation. Then we performed high-resolution untargeted metabolomics and RNAseq analysis of human nasal epithelial cells (hNECs) infected with H1N1 virus. Surprisingly, H1N1 virus infection caused the differential expression of a large number of ferroptosis related genes and metabolites in hNECs. Furthermore, we have observed a significant reduction in Nrf2/KEAP1 expression, GCLC expression, and abnormal glutaminolysis. By constructing overexpression vector of GCLC and the shRNAs of GCLC and Keap1, we determined the role of NRF2-KEAP1-GCLC signaling pathway in H1N1 virus-induced ferroptosis. In addition, A glutaminase antagonist, JHU-083, also demonstrated that glutaminolysis can regulate the NRF2-KEAP1-GCLC signal pathway and ferroptosis. According to this study, H1N1 virus can induce the ferroptosis of hNECs via the NRF2-KEAP1-GCLC signal pathway and glutaminolysis, leading to nasal mucosal epithelial inflammation. This discovery is expected to provide an attractive therapeutic target for viral-induced nasal inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI